The Claim

Tumor-selective synergy between vitamin C and the ROS-responsive prodrug FAN-NM-CH3 occurs because cancer cells have intrinsic catalase deficiency, allowing vitamin C-induced hydrogen peroxide to accumulate and activate the prodrug, while normal mammary epithelial cells maintain high catalase levels that prevent hydrogen peroxide accumulation and protect against cytotoxicity.

Source: Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killing

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
18score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Vitamin C and the prodrug FAN-NM-CH3 work together selectively against cancer cells because cancer cells lack sufficient catalase to break down hydrogen peroxide, allowing the prodrug to activate, while normal mammary cells have enough catalase to prevent hydrogen peroxide buildup and avoid damage.

See the scientific wording

Tumor-selective synergy between vitamin C and the ROS-responsive prodrug FAN-NM-CH3 is driven by cancer cells' intrinsic deficiency in catalase activity, which allows vitamin C-induced hydrogen peroxide to accumulate and activate the prodrug, whereas normal mammary epithelial cells maintain high catalase levels that prevent H2O2 buildup and protect against cytotoxicity.

Why this might work

Cancer cells cannot break down hydrogen peroxide because they lack a key enzyme, so when vitamin C is present, hydrogen peroxide builds up inside them. This triggers a special drug to release a poison that damages DNA. The high iron levels in cancer cells turn the hydrogen peroxide into an even more destructive force, making the damage worse. Normal cells have plenty of the enzyme to remove hydrogen peroxide, so the drug stays inactive and they stay unharmed.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killing

    Cancer cells can't break down a harmful chemical called hydrogen peroxide, so when they get vitamin C and this special drug together, the chemical builds up and kills them. Normal breast cells can break it down, so they stay safe.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.